Simon MacKenzie
Chief Business Officer
Censo Biotechnologies
Presentation(s):
-
Monday, February 5
6:42 PM – 7:22 PM
Late Night with LRIG
Censo Biotechnologies - Assessing patient population therapeutic response variability using human iPSC derived microglia
Monday, February 5
6:42 PM - 7:22 PM
Location: Room 8
-
Simon MacKenzie
Chief Business Officer
Censo Biotechnologies
Discovery drug development with human cells. Determining the next steps in CNS discovery using human neurons and microglia; disease sourced biosamples generating iPSC neurons to confirm targets, pathway hypothesis and confirm lead efficacy.